Navigation Links
Treatment for Syndrome X

Syndrome X is a disorder that many people are at risk for developing by the time they reach middle age. Syndrome X is why many people feel lousy and tired all the time, and it can put them at risk// for health problems such as heart disease, diabetes, Alzheimer's, cancer and other age-related diseases.

Syndrome X refers specifically to the health problems that include insulin resistance, abnormal blood fats, overweight and high blood pressure. New research shows an effective solution for syndrome X is the combination of exercise and weight loss.

Researchers conducted a study to determine if a six-month intervention could have an effect on coronary heart disease risk factors associated with syndrome X.

The study included 53 men and women who were part of a larger clinical trial. The participants suffered from insulin resistance, abnormal blood fats and high blood pressure. They were randomly assigned to the exercise only group, exercise and structured weight-loss program group, or the group that was on the waiting list for treatment. Before and after treatment, the participants underwent a variety of tests including glucose tolerance, lipid levels and blood pressure measurements.

Researchers found the response to glucose in the body was significantly reduced in both the exercise only and exercise/weight-loss groups. They say participants who lost the most amount of weight showed the most improvements in abnormal insulin responses. Researchers also report the diastolic blood pressure level was significantly reduced in the exercise/weight-loss group, but not in the exercise only group. The lipid or fat profile was not significantly improved in either intervention group.

Researchers thus conclude, the combination of exercise and weight loss is an effective treatment for hyperinsulinemia (failure of blood sugar control system) and lowering diastolic blood pressure in patients with syndrome X.


'"/>




Page: 1

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... , ... December 08, 2016 , ... ... Research Institute (WCRI) officially opened registration today for its 33rd Annual Issues ... Boston, MA . , The theme of the conference is “Persistent Challenges and ...
(Date:12/8/2016)... NJ (PRWEB) , ... December 08, 2016 , ... CURE ... cancer centers and advocacy groups, has aligned with Upstage Lung Cancer in efforts to ... making the announcement, Michael J. Hennessy, Jr said, “CURE Media Group is honored to ...
(Date:12/8/2016)... (PRWEB) , ... December 08, ... ... Presence Suite 10.2 version gives development continuity to its innovative Unified Instance ... channels management capacity. In addition, this new version optimizes the unattended auto-dialing ...
(Date:12/8/2016)... ... 08, 2016 , ... Today’s patients are encouraged to be ... SIGVARIS has created a new line of anti-embolism stockings to help prevent a ... benefits of graduated compression when transitioning from recovery to early rehabilitation. , The ...
(Date:12/8/2016)... ... 08, 2016 , ... The Dan Carlisle Agency, an Alabama-owned ... is announcing the launch of a charity drive to raise support and awareness ... and children in Birmingham has grown steadily since the 1980’s, and the Pathways ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... DUBLIN , Dec 8, 2016 Research and Markets ... Report" report to their offering. ... This report analyzes the worldwide markets for ... US, Canada , Japan , ... , and Rest of World. Annual estimates and forecasts are provided ...
(Date:12/8/2016)... , Dec. 8, 2016   TriNetX , ... Nationwide Children,s Hospital signed a membership agreement ... the development of new cures. The ... over 57 million patients globally, biopharmaceutical companies and ... to improve protocol design, site selection, patient recruitment, ...
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals ... TSX: VRX) ("Valeant") today announced positive results from ... study to assess the safety and efficacy of ... treatment of plaque psoriasis. Within ... with moderate to severe psoriasis, IDP-118 showed statistical ...
Breaking Medicine Technology: